Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Dr. Joseph R. Testa Appointed as Senior Editor for Cancer Research
PHILADELPHIA (August 3, 2015) – Joseph R. Testa, PhD, professor and Carol and Kenneth E. Weg Chair of Human Genetics at Fox Chase Cancer Center, has been appointed to serve as senior editor for Cancer Research, a journal of the American Association for Cancer Research.
Testa specializes in cancer genetics, specifically AKT and mesothelioma, at Fox Chase. He will serve as editor of the molecular and cellular pathobiology section of the journal for a three-year term. As a senior editor, Testa will be part of the peer review process for the most frequently cited oncology journal in the world.
“It is an honor to be appointed to this position,” said Testa. “Cancer Research leads our field, and those who submit papers have put a lot of time and effort into their studies. I hope to bring a unique insight into the process of selection.”
Cancer Research publishes original studies, reviews and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiology research.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427